How Did These Data Get Here? Recommendations for the Analysis of Data From ClinicalTrials.gov
A paper by Drs Okada and Sengoku that appears in this issue of TIRS shows how data from Clinicaltrials.gov can be used for research on the pharmaceutical industry. This commentary identifies several challenges associated with using these data for research and concludes with 3 recommendations from a statistical perspective.
| Errataetall: |
CommentOn: Ther Innov Regul Sci. 2019 Sep;53(5):648-653. - PMID 30428715 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:53 |
|---|---|
| Enthalten in: |
Therapeutic innovation & regulatory science - 53(2019), 5 vom: 07. Sept., Seite 639-640 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Durham, Todd A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Clinicaltrials.gov |
|---|
| Anmerkungen: |
Date Completed 31.03.2020 Date Revised 31.03.2020 published: Print-Electronic CommentOn: Ther Innov Regul Sci. 2019 Sep;53(5):648-653. - PMID 30428715 Citation Status MEDLINE |
|---|
| doi: |
10.1177/2168479018811825 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM290443687 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM290443687 | ||
| 003 | DE-627 | ||
| 005 | 20231225064739.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/2168479018811825 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0968.xml |
| 035 | |a (DE-627)NLM290443687 | ||
| 035 | |a (NLM)30411627 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Durham, Todd A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a How Did These Data Get Here? Recommendations for the Analysis of Data From ClinicalTrials.gov |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.03.2020 | ||
| 500 | |a Date Revised 31.03.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Ther Innov Regul Sci. 2019 Sep;53(5):648-653. - PMID 30428715 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a A paper by Drs Okada and Sengoku that appears in this issue of TIRS shows how data from Clinicaltrials.gov can be used for research on the pharmaceutical industry. This commentary identifies several challenges associated with using these data for research and concludes with 3 recommendations from a statistical perspective | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a Clinicaltrials.gov | |
| 650 | 4 | |a observational research | |
| 773 | 0 | 8 | |i Enthalten in |t Therapeutic innovation & regulatory science |d 2013 |g 53(2019), 5 vom: 07. Sept., Seite 639-640 |w (DE-627)NLM243752342 |x 2168-4804 |7 nnns |
| 773 | 1 | 8 | |g volume:53 |g year:2019 |g number:5 |g day:07 |g month:09 |g pages:639-640 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/2168479018811825 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 53 |j 2019 |e 5 |b 07 |c 09 |h 639-640 | ||